Capitolis Liquid Global Markets’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$96.4M Buy
196,173
+74,361
+61% +$40.4M 0.61% 30
2025
Q4
$70.6M Buy
121,812
+23,812
+24% +$13.5M 0.42% 56
2025
Q3
$47.5M Sell
98,000
-238,600
-71% -$111M 0.38% 53
2025
Q2
$136M Sell
336,600
-23,000
-6% -$9.62M 1% 22
2025
Q1
$179M Sell
359,600
-5,000
-1% -$2.71M 1.58% 15
2024
Q4
$190M Buy
364,600
+80,000
+28% +$44M 1.85% 14
2024
Q3
$176M Sell
284,600
-400
-0.1% -$237K 1.87% 15
2024
Q2
$158M Buy
285,000
+80,000
+39% +$45.8M 1.95% 14
2024
Q1
$119M Buy
+205,000
New +$115M 1.91% 17

Other funds holding TMO

Capitolis Liquid Global Markets's TMO Position: Q1 2026 in Review

Capitolis Liquid Global Markets increased its Thermo Fisher Scientific (TMO) stake by 61% in Q1 2026, buying an estimated $40.4M and bringing the position to 196,173 shares worth $96.4M. The position accounts for 0.61% of the portfolio, ranked #30.

Capitolis Liquid Global Markets first reported a position in TMO in Q1 2024 and has held it in 9 quarters since. The position peaked at $190M in Q4 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Capitolis Liquid Global Markets held 196,173 shares of Thermo Fisher Scientific worth $96.4M as of Q1 2026.
  • Capitolis Liquid Global Markets bought 74,361 Thermo Fisher Scientific shares in Q1 2026, an estimated $40.4M.
  • Thermo Fisher Scientific made up 0.61% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #30 holding.
  • Capitolis Liquid Global Markets first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 9 quarters since.
  • Capitolis Liquid Global Markets's Thermo Fisher Scientific position peaked at $190M in Q4 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.